Terbinafine HCL 250 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F94X2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,431
Award facts
- Contract value 100% obligated
- $4,430.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,430.69 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on December 9, 2025, with completion scheduled for December 10, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The award is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor specializing in supplying a comprehensive range of pharmaceutical products and medical supplies to defense and military healthcare systems. The company's extensive portfolio of federal contracts with the DLA encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for Terbinafine HCL—an antifungal medication—exemplifies the company's role in supporting routine pharmaceutical supply needs for military and veteran healthcare systems through the DLA's Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F94X2?
SPE2DR26F94X2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F94X2 worth?
The government has obligated $4,431 on SPE2DR26F94X2.
Is contract SPE2DR26F94X2 an order under another contract?
Yes. SPE2DR26F94X2 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F94X2 competed?
The extent of competition for SPE2DR26F94X2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award